Analgesics for pediatric use.
The use of nimesulide is increasing and recently, concerns have been raised regarding its hepatotoxicity, especially in children. At least two deaths due to fulminant hepatic failure have been attributed to nimesulide. In India, nimesulide has been approved and about twelve pediatric preparations are available. Lack of effective postmarketing surveillance means that adverse drug reactions may not be picked or reported. Therefore, quick approval of those drugs for which substitutes are available may not be desirable in India and in other developing countries.
Malhotra
S
S
Department of Clinical Pharmacology, PGIMER, Chandigarh.
Pandhi
P
P
D000367:Age Factors; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval; D005260:Female; D006801:Humans; D007194:India; D007223:Infant; D007231:Infant, Newborn; D008099:Liver / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010372:Pediatrics / Q000379:methods; D018570:Risk Assessment; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*
D000700:Analgesics; D013449:Sulfonamides; C012655:nimesulide